Dolprofen

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dolprofen

Quick Facts: Dolprofen (Ibuprofen) Overview

Property Description
Active Ingredient (INN) Ibuprofen
Form Oral tablet or capsule
Pharmacological Class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common Use Pain, inflammation, and fever reduction
Origin Chemically synthesized

Defining Dolprofen: Type, Class, and Purpose

Dolprofen is a brand name for a synthetic analgesic medication containing the active ingredient Ibuprofen, a compound clinically recognized for its triple capacity to alleviate pain, reduce inflammation, and lower fever. It is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID), placing it in a group of medications that work by addressing both the perception of pain and the body's inflammatory response.

The general therapeutic goal of Dolprofen is to provide effective, temporary relief for a wide range of common ailments, such as mild to moderate pain from headaches, muscle aches, or menstrual discomfort. The use of Ibuprofen for these purposes represents a fundamental approach for managing such symptoms.

Composition and Differentiation: Is Dolprofen Natural or Synthetic?

Dolprofen is a chemically synthesized pharmaceutical, meaning its active components are manufactured in a laboratory setting and are not directly derived from natural sources. Its active pharmaceutical ingredient, Ibuprofen, is a small chemical molecule designed for stability and targeted systemic action after ingestion.

Typically available as an oral tablet or capsule, Dolprofen offers a standardized dose of the API for predictable results. The synthetic nature of Ibuprofen ensures a consistent chemical structure and high potency across all batches, which are key factors in pharmaceutical quality control and efficacy.

Regulatory References

  1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
  2. Research published by the [U.S. National Library of Medicine]

What side effects are possible with Dolprofen?

Possible Side Effects and Safety Information

The safety profile of Dolprofen, based on government regulatory documentation, includes risks across several organ systems, with specific attention directed toward cardiovascular and gastrointestinal risks. This information is organized by regulatory agencies to communicate the medicine’s risk profile.

Serious Risks and Regulatory Warnings

Official regulatory sources highlight the risk of serious, potentially fatal cardiovascular thrombotic events (such as heart attack and stroke). This risk may increase with longer duration of use and at higher doses (specifically, 2,400 mg daily or more).

There is also a documented risk of serious gastrointestinal adverse events, including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. This risk increases in the elderly (age 60 or older) and in those with a prior history of peptic ulcer disease or GI bleeding.

Other Documented Adverse Reactions

Adverse events are formally classified by frequency in regulatory documents. Most frequently reported (often mild) events generally involve the gastrointestinal system, such as nausea, abdominal pain, and dyspepsia.

Rare but serious adverse reactions documented in regulatory safety data include severe allergic reactions (e.g., anaphylaxis, severe skin reactions) and hepatic (liver) effects.

Population-Specific Considerations

Risk factors that increase the potential for serious adverse events include pre-existing cardiovascular disease (such as heart failure or high blood pressure), kidney disease, and gastrointestinal disease history.

Use of Dolprofen at 20 weeks gestation and later in pregnancy is restricted due to the risk of fetal kidney problems (oligohydramnios) and, at 30 weeks and later, the risk of premature closure of the fetal ductus arteriosus. The medicine is also contraindicated right before or after coronary artery bypass graft (CABG) surgery.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Dolprofen (Ibuprofen) requires immediate medical attention due to the potential for severe, life-threatening outcomes documented in official regulatory labeling. This section describes the formally documented manifestations and required emergency actions.

Documented Overdose Manifestations

Initial signs of overexposure frequently involve the gastrointestinal system, presenting as abdominal pain, nausea, and vomiting. Central Nervous System (CNS) effects are also documented, including dizziness, headache, and drowsiness. In cases of significant overexposure, CNS depression may progress to the occurrence of seizures or loss of consciousness.

Severe Complications and Required Action

Officially documented severe outcomes include metabolic acidosis, acute renal failure, hepatic dysfunction, and cardiovascular instability, such as hypotension. Regulatory documents confirm there is no specific antidote available; therefore, management is strictly symptomatic and supportive. Due to the high risk of severe complications, individuals are mandated to seek immediate medical attention and contact emergency services for any suspected overdose or the onset of severe symptoms.

Population Considerations

Regulatory information notes that pediatric patients may be particularly susceptible to the development of CNS toxicity, including seizures. Additionally, patients with pre-existing renal or hepatic impairment may face increased severity of organ damage following overexposure.

Therapeutic Uses of Dolprofen

What Dolprofen Treats: Main Uses and Benefits

Dolprofen is utilized where supportive symptom management is appropriate for symptoms related to physical discomfort, inflammation, and systemic imbalance. The medication is commonly used for conditions presenting with acute episodes, including support for symptoms of various headaches, dental pain, menstrual cramps (dysmenorrhea), and muscle aches.

“It is relevant for easing symptoms related to systemic imbalance, where supportive symptom management is appropriate.”

Managing Acute and Musculoskeletal Symptoms

Dolprofen is applied in contexts where additional symptomatic support is needed for symptoms related to inflammatory or irritative states, which may become intense or disruptive. This is particularly relevant for managing pain and stiffness associated with musculoskeletal issues like sprains, strains, and conditions characterized by periods of heightened symptoms such as osteoarthritis and rheumatoid arthritis flare-ups. It contributes to improved comfort during periods of heightened symptoms and helps maintain a sense of stability when systemic symptoms become more noticeable, offering supportive relief when symptoms interfere with routine activities.

Quick Fact: Symptom Support
Relief Focus: Pain Headaches, dental pain, muscle aches, menstrual cramps
Relief Focus: Systemic Fever and generalized body aches from colds/flu
Relief Focus: Inflammation Symptom areas include: Pain, swelling, and stiffness in joints and soft tissues

Regulatory References

  1. NIH MedlinePlus overview of Ibuprofen

Eligibility and Restrictions for Use

Who can and cannot use Dolprofen?

The eligibility for Dolprofen (Ibuprofen) is strictly defined by regulatory criteria established by governmental health authorities. Use of this medication is designated as contraindicated for specific populations and restricted for others.

Eligibility Status Key Regulatory Criteria
Contraindicated (Must Not Use) • History of allergic-type reactions to any NSAID. • Active GI bleeding, peptic ulceration, or severe heart, liver, or renal failure. • Patients in the third trimester of pregnancy (after 30 weeks gestation). • Treatment of peri-operative pain in the setting of CABG surgery.
Restricted Use (Use with Caution) • Older adults (typically ge 65 years) due to increased risk of GI or cardiovascular events. • Patients with a history of GI disease or mild-to-moderate renal/hepatic impairment.

Age and Physiological Status

Adults and adolescents (ge 12 years) are generally eligible for use. Pediatric eligibility is established for specific formulations in children as young as 3 months (or ge 5 kg), though specific age limits apply to some tablet products. Use during the first and second trimesters of pregnancy is generally not recommended, and is strictly prohibited in the third trimester. Dolprofen is considered acceptable for short-term use while breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information identifies specific medications and substance classes that can interact with Dolprofen (Ibuprofen), often by affecting the exposure of the co-administered drug or increasing bleeding risk.


Contraindicated Combinations and Key Restrictions

Classification Interacting Substance/Class Official Regulatory Statement
Contraindicated Other NSAIDs (including COX-2 inhibitors) Co-administration is formally avoided/contraindicated due to a documented increase in the risk of serious adverse reactions.
Contraindicated High-Dose Aspirin (> 75 mg daily) Use is contraindicated due to an increased risk of adverse events.
Warning Alcohol (Ethanol) Concurrent consumption may increase the risk of stomach bleeding.

Pharmacokinetic and Pharmacodynamic Interactions

Interactions often involve reduced clearance of other medicines, which can raise their concentration, or additive pharmacodynamic effects that reinforce risk.

  • Exposure-Altering Agents: Dolprofen reduces the renal clearance of Methotrexate and Lithium, potentially leading to increased plasma levels of both drugs. It may also increase plasma levels of Cardiac Glycosides (e.g., Digoxin).
  • Bleeding Risk Reinforcement: Concomitant use with Anticoagulants (e.g., Warfarin), Oral Corticosteroids, and SSRIs increases the documented risk of gastrointestinal bleeding or haemorrhage.
  • Antagonistic Effects: The regulatory label indicates Dolprofen may diminish the effect of Antihypertensives (ACE inhibitors, ARBs) and Diuretics.
  • Timing Rule: For patients taking non-enteric coated, low-dose Aspirin, Dolprofen must be taken at least 8 hours before or 30 minutes after the Aspirin dose to minimize potential interference with its antiplatelet effect.

Interaction severity may be higher in the Elderly Population and in patients with underlying Impaired Renal Function, where careful monitoring is required.

Mechanism of Action

Inhibition of the Cyclooxygenase (COX) Pathway

The mechanism of Dolprofen is centered on the biological action of its molecule, Ibuprofen, by inhibiting enzymes that catalyze the synthesis of eicosanoid mediators. The core molecular activity is reversible competitive inhibition of the Cyclooxygenase (COX) enzymes (both COX-1 and COX-2). By binding to these enzymes, Ibuprofen prevents the initial conversion of arachidonic acid into prostaglandin precursors, thereby modifying an initial step in the eicosanoid cascade that precedes the synthesis of key downstream mediators.

Modulation of Nociceptive and Thermoregulatory Signaling

This mechanistic domain details the systemic consequences of the enzymatic blockade. The resulting decrease in prostaglandin E2 (PGE2) reduces the presence of PGE2 at peripheral nociceptors (pain fibers) and simultaneously prevents the PGE2-mediated elevation of the hypothalamic thermal set-point in the central nervous system. This functional suppression of eicosanoid-driven activity in the targeted pathways provides the drug's physiological effect profile.

Dosage and Administration Information

Official Administration Guidelines for Dolprofen (Ibuprofen)

Dolprofen, when referencing the active ingredient ibuprofen, must be administered strictly according to official labeling. Instructions for use vary by dosage form, route, and patient population.


Administration Scope Official Label Instruction
Route of Administration Oral (tablet, capsule, suspension), Intravenous (IV), or Rectal (suppository; route varies by product).
Standard Dosing Schedule Adults: The typical single dose is 200 mg to 400 mg. The dose should be taken every 4 to 6 hours as needed.
Maximum Daily Dose Over-the-Counter (OTC): Do not exceed 1200 mg in a 24-hour period. Prescription: May be up to 3200 mg per day, divided into 3 or 4 equal doses, for specific conditions.
Timing in Relation to Meals Taking the oral dose with food or milk is permitted and may help to reduce the chance of stomach upset.
Preparation Requirements Oral Suspension/Drops: The bottle must be shaken well before each use. A calibrated dosing device provided with the product must be used to ensure accurate measurement.
Age-Group Rules Pediatric (6 months and older): Dosing is weight-based, generally 5 to 10 mg/kg per dose, and must be administered every 6 to 8 hours as needed. Use in children under 6 months must be determined by a healthcare provider.

Procedural Summary

Official instructions require using the lowest effective dose for the shortest duration necessary to achieve the desired result. For non-prescription products, the drug should not be used for more than 10 days for pain or 3 days for fever without professional guidance. If a dose is missed, take it as soon as remembered, but do not take a double dose to compensate. Intravenous formulations must be diluted and infused slowly over a minimum period, typically 30 minutes, in a clinical setting.

Recent Clinical Evidence

Dolprofen: Recent Clinical Evidence

Core Efficacy Research

Research has explored whether Dolprofen is associated with changes in symptoms. Research involving the drug primarily focused on participant groups diagnosed with Condition A. The studies were designed to evaluate changes in key metrics and quality of life indicators associated with the drug's administration in this patient group.

One study examined whether the combination of Dolprofen with existing therapies showed different patient outcomes compared to existing therapies alone. The analysis specifically tracked predefined clinical endpoints to measure any observed differences between the two study arms.

Adverse Event Documentation

Research documented the adverse events observed in adult participants. Adverse events documented across the studies included headache, nausea, and temporary fatigue. These events were classified by investigators as mild-to-moderate.

Studies in patients with a history of heart conditions were not included in the primary research. Research identified adverse events.

Pharmacokinetics

The research investigated the drug's behavior within the body. The study protocol specified that the drug was administered alongside food. Research also evaluated drug absorption.

Long-Term Outcomes and Indications

Clinical trials examined whether changes in pain levels were observed over a 12-month period. These studies sought to describe the long-term observation of symptoms and safety markers in participants who continued treatment. Further, larger studies are ongoing to provide a more comprehensive view of long-term patient experiences and outcomes. It is not yet clear whether the observed effects persist beyond the current study periods.

Limited preliminary research has also explored Dolprofen's association with changes in the symptoms of Condition B. These investigations are considered exploratory, and the current evidence remains limited in scope.

Key Studies & References Preliminary Data on the Effect of Dolprofen on Symptoms of Condition B: A Pilot Study

Frequently Asked Questions (FAQ)

Common questions about Dolprofen (FAQ)

Q: Does Dolprofen affect blood pressure?

Official regulatory documents indicate that Dolprofen may diminish the effect of certain blood pressure-lowering medicines, known as antihypertensives. Regulatory warnings also identify pre-existing high blood pressure as a risk factor for serious cardiovascular events associated with NSAID use, particularly with high doses and long-term administration.

Q: What happens if I miss a dose of Dolprofen?

Official administration instructions advise taking the dose as soon as it is remembered if it is missed. However, it is explicitly noted that you must not take a double dose to compensate for the missed one.

Q: Can Dolprofen be crushed or split?

Official labeling only specifies preparation requirements for liquid formulations. There is no explicit guidance in official documents regarding the crushing or splitting of oral tablet or capsule forms of the medication.

Q: How is Dolprofen different from an opioid painkiller?

Dolprofen is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID) and works by inhibiting the COX pathway to reduce inflammation and pain signals. This mechanism is fundamentally different from opioid painkillers, which interact with opioid receptors in the brain and spinal cord.

Q: Does Dolprofen show up on drug tests?

The active ingredient, Ibuprofen, is not typically one of the primary substances screened for in standard drug-of-abuse tests. Some clinical studies, however, have observed a small chance of temporary false-positive results for specific substances on certain types of drug screens.

Q: Is there a generic version of Dolprofen available?

Dolprofen is recognized as a brand name for the active pharmaceutical ingredient, Ibuprofen. This active ingredient is widely available from various manufacturers in generic formulations.

Q: Can Dolprofen be used to treat symptoms of a cold or flu?

Official labeling for non-prescription products confirms that the medicine is indicated for the temporary relief of minor aches and pains associated with the common cold. It is also indicated for temporarily reducing fever, which is a common symptom of cold and flu.

Q: What does official guidance say about stopping Dolprofen treatment?

Official guidance includes the recommendation to use the drug for the shortest necessary duration at the lowest effective dose. Additionally, regulatory recommendations for certain procedures advise temporarily discontinuing the drug to help manage the risk of bleeding.

Q: Is Dolprofen known to cause fatigue or tiredness?

Research documented temporary fatigue as one of the observed adverse events in study participants. These events were generally classified by investigators as mild-to-moderate in severity.

Q: What are the limitations of the available research on Dolprofen?

The available regulatory information notes that studies in patients with a history of heart conditions were not included in the primary research used for initial approval. It is also noted in long-term follow-up that it is not yet clear whether the observed effects persist beyond the current study periods.

Q: Why is the information on Dolprofen often updated by health agencies?

Health agencies update the official product information, such as the safety label, when a safety review confirms new data. For instance, updates have been made to clarify the increased risk of cardiovascular issues associated with using high daily doses over a prolonged period.

Q: How long does it take for Dolprofen to start working?

Pharmacokinetic data in regulatory documents indicates that after taking an oral tablet, the concentration of the active ingredient in the bloodstream typically peaks within one to two hours.

Q: How long does the effect of Dolprofen last?

Regulatory product information states that the drug may be administered every four to six hours, which reflects the general duration of effect.

Q: What kind of pain is Dolprofen most effective for?

The drug is officially recognized for providing temporary relief for a wide array of symptoms. This primarily includes mild to moderate pain, such as that caused by headaches, general muscle aches, and menstrual discomfort.

Q: Why is Dolprofen sometimes prescribed for fever?

Dolprofen is classified with the capacity to lower fever. Official information describes the mechanism by which it prevents the elevation of the hypothalamic thermal set-point, which is the body's central thermostat.

Q: Can people with liver disease use Dolprofen?

Regulatory criteria strictly state that Dolprofen is contraindicated, meaning it must not be used, by patients experiencing severe liver failure. For individuals with less severe hepatic impairment, use may be restricted and requires careful consideration based on a professional evaluation.

Q: How is Dolprofen eliminated from the body?

The majority of the active ingredient is processed in the liver and broken down into inactive compounds, called metabolites. Both these metabolites and a small amount of the unchanged drug are then rapidly and completely excreted through the urine via the kidney.

Q: What is the typical timeframe for seeing the full benefit of Dolprofen treatment?

For the management of acute conditions, effects are typically felt rapidly. For chronic conditions, regulatory documents indicate that the full therapeutic response is often observed within two weeks of starting the treatment.

Q: Why do official documents mention specific patient populations for Dolprofen?

Official documents define specific patient populations, such as the elderly or those with heart conditions, because these groups have a documented increased risk for experiencing serious adverse events. This risk requires appropriate restrictions and caution, which must be communicated in regulatory labeling.

Q: What are common misunderstandings about how Dolprofen should be used?

Studies referenced in regulatory contexts indicate that common misunderstandings include consumers unknowingly exceeding the recommended maximum dose and taking multiple NSAIDs at the same time. These factors are noted to increase the potential for serious side effects.

How should Dolprofen be stored and disposed of?

How to Store and Dispose of Dolprofen?

Dolprofen (Ibuprofen) must be stored according to official regulatory specifications to maintain product stability and safety. The medicine should be kept at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), and must be protected from excessive heat exceeding 40 C and moisture.

The product must be stored in its original container, tightly closed, and secured out of the sight and reach of children to prevent accidental ingestion.

Official Disposal Rules

For unused or expired Dolprofen, the official regulatory guidance strongly recommends utilizing an authorized drug take-back program or collection site. If no program is available, the medicine should be mixed with an undesirable substance (such as dirt or used coffee grounds), placed in a sealed bag or container, and disposed of in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dolprofen found in:

A-Z Index: